20/06/2026
🎓 Continuing academic initiative of WHIRA Rheuma Classes | Disease Activity Assessment & Tools in SLE
An insightful and highly interactive academic session by Dr. Ranjan Gupta (Additional Professor, Department of Rheumatology, AIIMS New Delhi) moderated by Dr. Kavita Krishna and Dr. Varsha Bhatt took over 3900 participants through the evolving landscape of disease activity assessment in Systemic Lupus Erythematosus (SLE).
The session highlighted:
🔹 The crucial distinction between disease activity and irreversible damage, and why differentiating the two is fundamental to patient care.
🔹 Why standardized disease activity assessment is essential for clinical decision-making, prognostication, treat-to-target strategies, and research.
🔹 A comprehensive overview of commonly used indices, including SLEDAI-2K, SELENA-SLEDAI, BILAG-2004, ECLAM, SLAM-R, LAI, and SLE-DAS, with their strengths, limitations, and ideal clinical applications.
🔹 Special considerations for disease activity assessment during pregnancy, emphasizing appropriate interpretation of clinical and laboratory findings.
The session concluded with a comparative approach to selecting the most appropriate assessment tool based on clinical context, reinforcing that accurate disease activity measurement is central to optimizing outcomes in lupus.
A sincere thank you to Dr. Ranjan Gupta for sharing his expertise and making complex assessment tools practical and clinically relevant for rheumatology trainees and practicing clinicians.